首页> Oncotarget> MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.

MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Shaohui,Tang

第一单位： Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China.

作者： Shaohui,Tang ^[1] ; Yanfang,Chen ^[1] ; Shufen,Feng ^[1] ; Tingzhuang,Yi ^[2] ; Xuyou,Liu ^[3] ; Qiang,Li ^[4] ; Zhilong,Liu ^[4] ; Cuiping,Zhu ^[1] ; Jianjun,Hu ^[1] ; Xi,Yu ^[1] ; Min,Wang ^[1] ; Guoli,Cao ^[1] ; Hui,Tang ^[5] ; Caiqun,Bie ^[6] ; Feng,Ma ^[1] ; Huijun,Tang ^[6] ; Gang,Du ^[5] ; Jianwei,Huang ^[3]

作者单位： Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China. ^[1] Department of Gastroenterology, Affiliated Hospital of Youjiang Medical University for Nationlities, Baise, Guangxi, China. ^[2] Department of Gastroenterology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. ^[3] Department of General Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China. ^[4] Clinical Medicine Research Institute, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China. ^[5] Department of Gastroenterology, The Affiliated Shenzhen Shajing Hospital, Guangzhou Medical University, Shenzhen, Guangdong, China. ^[6]

关键词 ago proteins inferior clinical outcome liver cancer miRNAs transcription regulation

DOI 10.18632/oncotarget.21737

PMID 29245946

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交